This week, we head up full speed from Geneva with our eyes aiming towards Paris. Known for its beauty, bohemian lifestyle and, of course the Eiffel Tower, the Louvre and le baguette, Paris is also the home of OSE Pharma, our Biotech of the Week.
City: Paris (France)
Financial Data: €24.3M total raised (as of 01/2016)
CEO: Dominique Costantini
Mission: OSE Pharma is developing immunotherapy products against invasive/metastatic late-stage cancers. Memopi, one of its key technologies and currently being developed for ovarian, colon and breast cancers.
The treatment helps the patient’s immune system remove malignant cancer cells, by ‘re-educating its immunological memory‘ in order to allow the immune system to attack tumor cells. By doing this, the patient’s cytotoxic T cells increase and are able to respond more efficiently to the cancer.